Kogieleum Naidoo

7.2k total citations · 3 hit papers
175 papers, 4.1k citations indexed

About

Kogieleum Naidoo is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Kogieleum Naidoo has authored 175 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Infectious Diseases, 99 papers in Epidemiology and 36 papers in Virology. Recurrent topics in Kogieleum Naidoo's work include Tuberculosis Research and Epidemiology (94 papers), HIV/AIDS Research and Interventions (54 papers) and Pneumocystis jirovecii pneumonia detection and treatment (53 papers). Kogieleum Naidoo is often cited by papers focused on Tuberculosis Research and Epidemiology (94 papers), HIV/AIDS Research and Interventions (54 papers) and Pneumocystis jirovecii pneumonia detection and treatment (53 papers). Kogieleum Naidoo collaborates with scholars based in South Africa, United States and United Kingdom. Kogieleum Naidoo's co-authors include Nesri Padayatchi, Salim S. Abdool Karim, Tanuja N. Gengiah, Quarraisha Abdool Karim, Navisha Dookie, Wafaa El‐Sadr, Anneke Grobler, Nonhlanhla Yende‐Zuma, Andy Gray and Gonasagrie Nair and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Kogieleum Naidoo

165 papers receiving 4.0k citations

Hit Papers

Timing of Initiation of Antiretroviral Drugs during Tuber... 2010 2026 2015 2020 2010 2018 2018 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
    2010 478 citations Salim S. Abdool Karim, Kogieleum Naidoo et al. profile →
  2. Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection
    2018 348 citations Keertan Dheda, Kogieleum Naidoo et al. profile →
  3. Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care
    2018 222 citations Navisha Dookie, Nesri Padayatchi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kogieleum Naidoo South Africa 31 3.2k 2.2k 1.0k 490 366 175 4.1k
Francesca Conradie South Africa 28 2.8k 0.9× 1.6k 0.7× 619 0.6× 507 1.0× 366 1.0× 91 3.4k
Christian Wejse Denmark 32 2.5k 0.8× 2.0k 0.9× 834 0.8× 353 0.7× 314 0.9× 202 4.3k
Nesri Padayatchi South Africa 37 3.6k 1.1× 2.7k 1.2× 1.1k 1.1× 188 0.4× 373 1.0× 131 4.4k
William J. Burman United States 47 4.8k 1.5× 3.6k 1.7× 1.3k 1.3× 561 1.1× 511 1.4× 121 6.8k
Adeeba Kamarulzaman Malaysia 35 2.1k 0.6× 2.0k 0.9× 321 0.3× 567 1.2× 216 0.6× 142 3.7k
Neel R. Gandhi United States 35 5.5k 1.7× 4.4k 2.0× 2.0k 1.9× 223 0.5× 696 1.9× 125 6.7k
Haileyesus Getahun Switzerland 28 3.8k 1.2× 3.0k 1.4× 1.5k 1.5× 146 0.3× 521 1.4× 57 4.8k
Matthew Bates United Kingdom 34 2.9k 0.9× 2.5k 1.1× 986 1.0× 212 0.4× 672 1.8× 93 4.3k
Brian Eley South Africa 40 3.6k 1.1× 2.2k 1.0× 895 0.9× 941 1.9× 180 0.5× 193 4.9k
Srikanth Tripathy India 36 2.6k 0.8× 1.5k 0.7× 600 0.6× 999 2.0× 440 1.2× 236 4.2k

Countries citing papers authored by Kogieleum Naidoo

Since Specialization
Citations

This map shows the geographic impact of Kogieleum Naidoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kogieleum Naidoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kogieleum Naidoo more than expected).

Fields of papers citing papers by Kogieleum Naidoo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kogieleum Naidoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kogieleum Naidoo. The network helps show where Kogieleum Naidoo may publish in the future.

Co-authorship network of co-authors of Kogieleum Naidoo

This figure shows the co-authorship network connecting the top 25 collaborators of Kogieleum Naidoo. A scholar is included among the top collaborators of Kogieleum Naidoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kogieleum Naidoo. Kogieleum Naidoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perumal, Rubeshan, et al.. (2025). The gut and lung microbiome across the TB disease spectrum. Frontiers in Microbiology. 16. 1643900–1643900.
2.
3.
Sobol, Robert W., Shaheed Vally Omar, Tyler S. Brown, et al.. (2025). Transmission of bedaquiline-resistant Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. American Journal of Respiratory and Critical Care Medicine. 212(1). 138–147.
4.
Dagnew, Alemnew F., Ling Han, Kogieleum Naidoo, et al.. (2025). Safety and immunogenicity of investigational tuberculosis vaccine M72/AS01E–4 in people living with HIV in South Africa: an observer-blinded, randomised, controlled, phase 2 trial. The Lancet HIV. 12(8). e546–e555. 2 indexed citations
5.
Manasa, Justen, Richard Lessells, Andrew Tomita, et al.. (2024). Patterns of HIV-1 Drug Resistance Observed Through Geospatial Analysis of Routine Diagnostic Testing in KwaZulu-Natal, South Africa. Viruses. 16(10). 1634–1634. 3 indexed citations
6.
Naicker, Nivashnee, Farzana Osman, Kogieleum Naidoo, et al.. (2024). High burden of human papillomavirus and premalignant cervical lesions among women starting HIV treatment in KwaZulu-Natal, South Africa. Sexually Transmitted Infections. 101(3). 187–190. 2 indexed citations
7.
Dawood, Halima, et al.. (2024). Southern African HIV Clinicians Society guideline on the management of non-tuberculous mycobacteria in people with HIV. Southern African Journal of HIV Medicine. 25(1). 1657–1657.
8.
Naidoo, Anushka, et al.. (2023). Polymorphisms within the SARS-CoV-2 Human Receptor Genes Associate with Variable Disease Outcomes across Ethnicities. Genes. 14(9). 1798–1798. 3 indexed citations
9.
Perumal, Rubeshan, et al.. (2023). Long COVID: An approach to clinical assessment and management in primary care. SHILAP Revista de lepidopterología. 65(1). e1–e10. 4 indexed citations
10.
Dorward, Jienchi, Yukteshwar Sookrajh, Thokozani Khubone, et al.. (2023). Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study. The Lancet HIV. 10(5). e284–e294. 25 indexed citations
11.
Mulenga, Humphrey, Andrew Fioré-Gartland, Simon C. Mendelsohn, et al.. (2022). The effect of host factors on discriminatory performance of a transcriptomic signature of tuberculosis risk. EBioMedicine. 77. 103886–103886. 4 indexed citations
12.
Mendelsohn, Simon C., Stanley Kimbung Mbandi, Andrew Fioré-Gartland, et al.. (2022). Prospective multicentre head-to-head validation of host blood transcriptomic biomarkers for pulmonary tuberculosis by real-time PCR. SHILAP Revista de lepidopterología. 2(1). 20 indexed citations
13.
Perumal, Rubeshan, Kogieleum Naidoo, Anushka Naidoo, et al.. (2022). The impact of enteral feeding and therapeutic monitoring of rifampicin with dose escalation in critically ill patients with tuberculosis. International Journal of Infectious Diseases. 126. 174–180. 4 indexed citations
14.
Dookie, Navisha, et al.. (2022). Application of Next Generation Sequencing for Diagnosis and Clinical Management of Drug-Resistant Tuberculosis: Updates on Recent Developments in the Field. Frontiers in Microbiology. 13. 775030–775030. 43 indexed citations
15.
Chimukangara, Benjamin, Richard Lessells, Benn Sartorius, et al.. (2021). HIV-1 drug resistance in adults and adolescents on protease inhibitor-based antiretroviral therapy in KwaZulu-Natal Province, South Africa. Journal of Global Antimicrobial Resistance. 29. 468–475. 12 indexed citations
16.
Mansoor, Leila E., Halima Dawood, Kogieleum Naidoo, et al.. (2020). Importance of early identification of PrEP breakthrough infections in a generalized HIV epidemic: a case report from a PrEP demonstration project in South Africa. BMC Infectious Diseases. 20(1). 532–532. 4 indexed citations
17.
Perumal, Rubeshan, Kogieleum Naidoo, Anushka Naidoo, et al.. (2020). A systematic review and meta-analysis of first-line tuberculosis drug concentrations and treatment outcomes. The International Journal of Tuberculosis and Lung Disease. 24(1). 48–64. 21 indexed citations
18.
Chimukangara, Benjamin, Ayesha B. M. Kharsany, Richard Lessells, et al.. (2018). Moderate-to-High Levels of Pretreatment HIV Drug Resistance in KwaZulu-Natal Province, South Africa. AIDS Research and Human Retroviruses. 35(2). 129–138. 23 indexed citations
19.
Loggerenberg, Francois van, Debra Gray, Santhanalakshmi Gengiah, et al.. (2015). A Qualitative Study of Patient Motivation to Adhere to Combination Antiretroviral Therapy in South Africa. AIDS Patient Care and STDs. 29(5). 299–306. 41 indexed citations
20.
Naidoo, Kogieleum, Quarraisha Abdool Karim, Kogieleum Naidoo, et al.. (2013). High Rates of Tuberculosis in Patients Accessing HAART in Rural South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(4). 438–446. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Conradie Breakdown of academic impact, for papers by Christian Wejse Breakdown of academic impact, for papers by Nesri Padayatchi Breakdown of academic impact, for papers by William J. Burman Breakdown of academic impact, for papers by Adeeba Kamarulzaman Breakdown of academic impact, for papers by Neel R. Gandhi Breakdown of academic impact, for papers by Haileyesus Getahun Breakdown of academic impact, for papers by Matthew Bates Breakdown of academic impact, for papers by Brian Eley Breakdown of academic impact, for papers by Srikanth Tripathy
Rankless by CCL
2026